Influences of cerebral stent implantation on CD4+CD25 +FOXP3+Treg, Th1 and Th17 cells

International Immunopharmacology

Volumn 17, Issue 3, 2013, Pages 519-525

  Wang, Sijia ^a   Ni, Bing ^a   Chen, Kangning ^a   Shi, Shugui ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Inflammation; Regulatory T cells; Stents; Th1 Th17

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CYTOKINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMPLANTATION; LOADING DRUG DOSE; LONG TERM CARE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; STENT IMPLANTATION; TH1 CELL; TH17 CELL;

INFLAMMATION; REGULATORY T CELLS; STENTS; TH1; TH17;

AGED; CAROTID STENOSIS; CONSTRICTION, PATHOLOGIC; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; STENTS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS;

EID: 84884521032     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.07.024     Document Type: Article

References (27)

1. T.R. Mosmann, and R.L. Coffman TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties Annu Rev Immunol 7 1989 145 173 (Pubitemid 19138011)
2. G.K. Hansson, L. Jonasson, P.S. Seifert, and S. Stemme Immune mechanisms in atherosclerosis Arteriosclerosis 9 1989 567 578 (Pubitemid 19236891)
3. P. Alexander, A. Walters, and G. Verghese Cherry pip bezoars causing acute small intestinal obstruction presenting as diabetic ketoacidosis Indian J Gastroenterol 24 2005 273 274 (Pubitemid 44326113)
4. S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases J Immunol 155 1995 1151 1164
5. L.E. Harrington, R.D. Hatton, P.R. Mangan, H. Turner, T.L. Murphy, and K.M. Murphy Interleukin 17-producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages Nat Immunol 6 2005 1123 1132 (Pubitemid 41541790)
6. + natural regulatory T cells in dominant self-tolerance and autoimmune disease Immunol Rev 212 2006 8 27 (Pubitemid 44116697)
7. P.J. Coffer, and B.M. Burgering Forkhead-box transcription factors and their role in the immune system Nat Rev Immunol 4 2004 889 899 (Pubitemid 39490764)
8. T. Korn, E. Bettelli, M. Oukka, and V.K. Kuchroo IL-17 and Th17 Cells Annu Rev Immunol 27 2009 485 517
9. J.J. Yu, and S.L. Gaffen Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity Front Biosci 13 2008 170 177 (Pubitemid 351594768)
10. V. Dardalhon, T. Korn, V.K. Kuchroo, and A.C. Anderson Role of Th1 and Th17 cells in organ-specific autoimmunity J Autoimmun 31 2008 252 256
11. A. Mor, G. Luboshits, D. Planer, G. Keren, and J. George Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes Eur Heart J 27 2006 2530 2537 (Pubitemid 44627295)
12. G. Sardella, L. De Luca, V. Francavilla, D. Accapezzato, M. Mancone, and M.I. Sirinian Frequency of naturally-occurring regulatory T cells is reduced in patients with ST-segment elevation myocardial infarction Thromb Res 120 2007 631 634 (Pubitemid 47094917)
13. S. Meguro, M. Ishibashi, and I. Takei The significance of high sensitive C reactive protein as a risk factor for cardiovascular diseases Rinsho Byori 60 2012 356 361
14. E. Rietzschel, and M. De Buyzere High-sensitive C-reactive protein: universal prognostic and causative biomarker in heart disease? Biomark Med 6 2012 19 34
15. M.R. Frankel, L.B. Morgenstern, T. Kwiatkowski, M. Lu, B.C. Tilley, and J.P. Broderick Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial Neurology 55 2000 952 959
16. K.W. Muir, C.J. Weir, G.D. Murray, C. Povey, and K.R. Lees Comparison of neurological scales and scoring systems for acute stroke prognosis Stroke 27 1996 1817 1820 (Pubitemid 26332512)
17. M.M. Glymour, L.F. Berkman, K.A. Ertel, M.E. Fay, T.A. Glass, and K.L. Furie Lesion characteristics, NIH stroke scale, and functional recovery after stroke Am J Phys Med Rehabil 86 2007 725 733 (Pubitemid 47300969)
18. L.H. Bonati, and G. Fraedrich Carotid Stenting Trialists C. Age modifies the relative risk of stenting versus endarterectomy for symptomatic carotid stenosis - a pooled analysis of EVA-3S, SPACE and ICSS Eur J Vasc Endovasc Surg 41 2011 153 158
19. T.G. Brott, R.W. Hobson II, G. Howard, G.S. Roubin, W.M. Clark, and W. Brooks Stenting versus endarterectomy for treatment of carotid-artery stenosis N Engl J Med 363 2010 11 23
20. A. Gaspardone, and F. Versaci Coronary stenting and inflammation Am J Cardiol 96 2005 65L 70L
21. O.J. de Boer, J.J. van der Meer, P. Teeling, C.M. van der Loos, M.M. Idu, and F. van Maldegem Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques J Pathol 220 2010 499 508
22. K. Hamzaoui Th17 cells in Behcet's disease: a new immunoregulatory axis Clin Exp Rheumatol 29 2011 S71 S76
23. B. Hoechst, J. Gamrekelashvili, M.P. Manns, T.F. Greten, and F. Korangy Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells Blood 117 2011 6532 6541
24. + T cells with potent suppressive function Eur J Immunol 41 2011 936 951
25. A. Farb, G. Sangiorgi, A.J. Carter, V.M. Walley, W.D. Edwards, and R.S. Schwartz Pathology of acute and chronic coronary stenting in humans Circulation 99 1999 44 52 (Pubitemid 29035956)
26. I. Shalev, M. Schmelzle, S.C. Robson, and G. Levy Making sense of regulatory T cell suppressive function Semin Immunol 23 2011 282 292
27. N. Sasaki, T. Yamashita, M. Takeda, and K. Hirata Regulatory T cells in atherogenesis J Atheroscler Thromb 19 2012 503 515